Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B John

Showing results (491-500 of 612) with videos related to

Pageof 62
Sort By:
Journal of the American College of Cardiology|August 27, 2013
Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)Subroto Acharjee, William E Boden, Pamela M Hartigan, et al.
Journal of the American College of Cardiology|November 6, 2020
Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary RevascularizationMichael E Farkouh, Lucas C Godoy, Maria M Brooks, et al.
The Canadian Journal of Cardiology|October 2, 2018
CardioDiabetes: Core Competencies for Cardiovascular Clinicians in a Rapidly Evolving Era of Type 2 Diabetes ManagementG B John Mancini, Alice Y Cheng, Kim Connelly, et al.
CJC Open|November 3, 2025
Vaccination in Patients with Cardiovascular Disease: A Case-Based Approach and Contemporary ReviewPhelopater Sedrak, Vera Dounaevskaia, G B John Mancini, et al.
Leukemia Research|May 23, 2020
Rigosertib in combination with azacitidine in patients with myelodysplastic syndromes or acute myeloid leukemia: Results of a phase 1 studyShyamala C Navada, Guillermo Garcia-Manero, Rosalie OdchimarReissig, et al.
Journal of the American Heart Association|January 19, 2024
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE TrialAbhinav Sharma, Amir Razaghizad, Abdulaziz Joury, et al.
Current Opinion in Cardiology|June 26, 2021
Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?Abhinav Sharma, Haya Aziz, Subodh Verma, et al.
Neoplasia (New York, N.Y.)|May 3, 2014
KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancerStina M Singel, Crystal Cornelius, Elma Zaganjor, et al.
Atherosclerosis|February 5, 2026
Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotypeG B John Mancini, Arnold Ryomoto, Isabelle Ruel, et al.
Pediatric Pulmonology|March 29, 2000
Obstructive sleep apnea syndrome in obese Singapore childrenO M Chay, A Goh, J Abisheganaden, et al.
Pageof 62

Showing results (491-500 of 612) with videos related to

Sort By:
Pageof 62
Journal of the American College of Cardiology|August 27, 2013
Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)Subroto Acharjee, William E Boden, Pamela M Hartigan, et al.
Journal of the American College of Cardiology|November 6, 2020
Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary RevascularizationMichael E Farkouh, Lucas C Godoy, Maria M Brooks, et al.
The Canadian Journal of Cardiology|October 2, 2018
CardioDiabetes: Core Competencies for Cardiovascular Clinicians in a Rapidly Evolving Era of Type 2 Diabetes ManagementG B John Mancini, Alice Y Cheng, Kim Connelly, et al.
CJC Open|November 3, 2025
Vaccination in Patients with Cardiovascular Disease: A Case-Based Approach and Contemporary ReviewPhelopater Sedrak, Vera Dounaevskaia, G B John Mancini, et al.
Leukemia Research|May 23, 2020
Rigosertib in combination with azacitidine in patients with myelodysplastic syndromes or acute myeloid leukemia: Results of a phase 1 studyShyamala C Navada, Guillermo Garcia-Manero, Rosalie OdchimarReissig, et al.
Journal of the American Heart Association|January 19, 2024
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE TrialAbhinav Sharma, Amir Razaghizad, Abdulaziz Joury, et al.
Current Opinion in Cardiology|June 26, 2021
Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?Abhinav Sharma, Haya Aziz, Subodh Verma, et al.
Neoplasia (New York, N.Y.)|May 3, 2014
KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancerStina M Singel, Crystal Cornelius, Elma Zaganjor, et al.
Atherosclerosis|February 5, 2026
Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotypeG B John Mancini, Arnold Ryomoto, Isabelle Ruel, et al.
Pediatric Pulmonology|March 29, 2000
Obstructive sleep apnea syndrome in obese Singapore childrenO M Chay, A Goh, J Abisheganaden, et al.
Pageof 62